Suez, Egypt – Bukyline Pharmaceutical Co., Ltd. reached a new height in 2024, earning a prestigious Product Innovation Award for its Cat Kidney Support Tablets. Announced earlier this year, the award recognized Bukyline’s dedication to advancing feline health through cutting-edge research and development.

Launched in early 2024, the Cat Kidney Support Tablets combined tasty flavors with high-efficacy ingredients, addressing a common health concern for cats. Dr. Emily Chen, who led the project, stated, “This award validates our focus on innovation and animal well-being—it’s a win for our team and our customers.” The recognition boosted Bukyline’s global profile, with orders surging from pet owners and veterinarians alike. Now in its third year, the company continues to prove that its young age belies a mature commitment to excellence, setting the stage for even greater achievements.